← Open Payments lookup

SUSAN ROBSON: Open Payments

NPI 1558827055 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$340 in 13 payments from 8 companies in 2025. Trend: 2023 $422 · 2024 $123 · 2025 $340

Food & beverage: $340
CompanyPaymentsAmount
Madrigal Pharmaceuticals5$140
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$44
Astellas Pharma US Inc1$30
ABBVIE INC.1$30
Ethicon US, LLC1$28
Intercept Pharmaceuticals, Inc.1$25
Gilead Sciences, Inc.1$23
Novo Nordisk Inc1$19

Products named: REZDIFFRA, XIFAXAN, Cresemba, MAVYRET, PROLENE, OCALIVA, Wegovy.

Industry payments across DC — which companies pay providers there.